Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile
Articles by Brian K. Do
Risk of intestinal complications, extraintestinal morbidity, and mortality in patients with ulcerative colitis and ocular involvement - Eye
Abstract To explore health outcomes of patients with ulcerative colitis (UC) and associated ocular inflammatory disease, compared to those of matched patients with UC without associated ocular inflammatory disease. Retrospective case-control study. An aggregated electronic health records research network, TriNetX (Cambridge, MA, USA), was used to identify patients diagnosed with UC stratified by the presence or absence of ocular inflammatory disease with at least one year of follow-up.
Real-world study finds low complication rates in vitrectomy for floaters
Key takeaways: Rates of endophthalmitis, retinal tear/detachment and hemorrhage were low. Vitrectomy remains a reasonable treatment for floaters. NEW YORK — Rates of complications in vitrectomy for floaters were low in a real-world study presented at OSN New York Retina. Brian K.
Comparing visual outcomes of nAMD treatment during and after the COVID-19 restrictions period
Citation: Chen MY, Du J, Do BK, Ali MH (2025) Comparing visual outcomes of nAMD treatment during and after the COVID-19 restrictions period. PLoS One 20(5): e0323253. https://doi.org/10.1371/journal.pone.0323253 Editor: Yalong Dang, Sanmenxia Central Hospital, Henan University of Science and Technilogy, CHINA Received: December 23, 2024; Accepted: April 6, 2025; Published: May 7, 2025 Copyright: © 2025 Chen et al.
Steroid Options for Treatment of Uveitis
Since corticosteroids were discovered in the 1950s, they have become and remain the mainstay of treatment for uveitis.1 Although the full mechanism of corticosteroids is not understood, it is believed that the basis for the anti-inflammatory and immunosuppressive effects of corticosteroids in the eye is the activation of the glucocorticoid receptor.
Faricimab approval, home OCT mark major developments in retina
April 23, 2022 1 min read Source/Disclosures Source: Do BK. The latest in retina: 5 things to know. Presented at: American Society of Cataract and Refractive Surgery meeting; April 22-26, 2022; Washington. Disclosures: Do reports having disclosures for Alimera, Allergan/AbbVie and Bausch + Lomb. ADD TOPIC TO EMAIL ALERTS Receive an email when new articles are posted on Please provide your email address to receive an email when new articles are posted on . We were unable to process your request.
Medical Management of Macular Holes
Medical Management of Macular Holes Christina Y. Weng, MD, MBA; Brian K. Do, MD; and Mrinali Gupta, MD Show Description + Medical Management of Macular Holes Christina Y. Weng, MD, MBA; Brian K. Do, MD; and Mrinali Gupta, MD As more data are published regarding medical intervention for macular hole closure, retina specialists want to know which patients are best suited for this approach and in which cases it may be most effective.
A case report of uveitis secondary to dupilumab treatment for atopic dermatitis
Key words adverse effect atopic dermatitis dupilumab eczema treatment uveitis Abbreviations used: AD (atopic dermatitis), IL (interleukin) Introduction Atopic dermatitis (AD) is a chronic inflammatory skin disease mediated by the helper T cell type 2 cytokines interleukin 4 (IL-4) and/or IL-13. 1 Gandhi N.A. Bennett B.L. Graham N.M. Pirozzi G. Stahl N. Yancopoulos G.D. Targeting key proximal drivers of type 2 inflammation in disease. Nat Rev Drug Discov.
Show More
loading
Actions
Is this you?
As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.Get in touch with Brian
Contact Brian, search articles and posts on X, monitor coverage, and track replies from one place.
Learn more about Muck Rack